Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to AGIO Full portfolio

Position in AGIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$51,046,957
+$5,547,198 QoQ
Shares Held
1,375,558
+2.3% QoQ
Ownership
2.30%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#12
of 239 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Derivatives in AGIO

reported options exposure · as of Jun 30, 2026
CallValue
$6,334,677
CallShares
170,700
PutValue
$5,080,359
PutShares
136,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. AGIO ranks #8 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
This page 		1,375,558 $51,046,957

All Filings in AGIO

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $51,046,957 1,375,558
2026-06-30 $5,080,359 136,900
2026-06-30 $6,334,677 170,700
2026-03-31 $3,954,727 116,900
2026-03-31 $45,499,759 1,344,953
2026-03-31 $3,196,935 94,500
2025-12-31 $24,604,158 903,900
2025-12-31 $22,755,920 836,000
2025-12-31 $31,096,999 1,142,432
2025-09-30 $6,727,464 167,600
2025-09-30 $10,729,422 267,300
2025-06-30 $1,995,600 60,000
2025-06-30 $1,237,272 37,200
2025-06-30 $2,265,105 68,103
2025-03-31 $2,176,990 74,300
2025-03-31 $1,072,380 36,600
2025-03-31 $2,401,486 81,962
2024-12-31 $3,548,880 108,000
2024-12-31 $5,602,761 170,504
2024-12-31 $2,106,326 64,100
2024-09-30 $853,944 19,220
2024-09-30 $275,466 6,200
2024-09-30 $2,603,598 58,600
2024-06-30 $514,421 11,930
2024-06-30 $2,811,424 65,200
2024-06-30 $3,622,080 84,000
2024-03-31 $2,371,364 81,100
2024-03-31 $642,022 21,957
2024-03-31 $1,678,376 57,400
2023-12-31 $501,743 22,530
2023-12-31 $1,912,993 85,900
2023-09-30 $467,799 18,901
2023-09-30 $1,447,875 58,500
2023-09-30 $1,633,500 66,000
2023-06-30 $1,161,120 41,000
2023-06-30 $631,790 22,309
2023-06-30 $427,632 15,100
2023-03-31 $2,754,057 119,898
2023-03-31 $305,501 13,300
2023-03-31 $1,107,154 48,200
2022-12-31 $693,576 24,700
2022-12-31 $756,447 26,939
2022-12-31 $370,656 13,200
2022-09-30 $885,164 31,300
2022-09-30 $1,080,296 38,200
2022-09-30 $1,494,682 52,853
2022-06-30 $416,796 18,800
2022-06-30 $791,469 35,700
2022-03-31 $1,895,061 65,100
2022-03-31 $331,854 11,400